Published: 2019-07-09

Foreword

The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders

Giorgio Ciprandi, Salvo Emanuele Aragona, Lorenzo Drago, Ignazio La Mantia
Abstract 182 | PDF Downloads 100 | DOI https://doi.org/10.23750/abm.v90i7-S.8648

Page 5-7

Original articles

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 290 | PDF Downloads 110 | DOI https://doi.org/10.23750/abm.v90i7-S.8649

Page 8-12

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

Luigi Bonavina, Andrea Ariani, Leonardo Ficano, Domenico Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Lorenzo Drago, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 232 | PDF Downloads 96 | DOI https://doi.org/10.23750/abm.v90i7-S.8650

Page 13-17

Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01)

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 137 | PDF Downloads 76 | DOI https://doi.org/10.23750/abm.v90i7-S.8651

Page 18-23

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 135 | PDF Downloads 85 | DOI https://doi.org/10.23750/abm.v90i7-S.8654

Page 24-29

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 157 | PDF Downloads 60 | DOI https://doi.org/10.23750/abm.v90i7-S.8655

Page 30-35

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 148 | PDF Downloads 61 | DOI https://doi.org/10.23750/abm.v90i7-S.8656

Page 36-40

VAS for assessing the perception of antihistamines use in allergic rhinitis

Giorgio Ciprandi, Ignazio La Mantia
Abstract 100 | PDF Downloads 61 | DOI https://doi.org/10.23750/abm.v90i7-S.8657

Page 41-44

Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers

Calogero Grillo, Ignazio La Mantia, Caterina M Grillo, Giorgio Ciprandi, Martina Ragusa, Claudio Andaloro
Abstract 178 | PDF Downloads 117 | DOI https://doi.org/10.23750/abm.v90i7-S.8658

Page 45-51

Oral health in children with sleep-disordered breathing: a cross-sectional study

Calogero Grillo, Ignazio La Mantia, Graziano Zappala, Salvatore Cocuzza, Giorgio Ciprandi, Claudio Andaloro
Abstract 205 | PDF Downloads 111 | DOI https://doi.org/10.23750/abm.v90i7-S.8661

Page 52-59